Short interest in Oramed Pharmaceuticals Inc (NASDAQ:ORMP) increased during the last reporting period, rising from 616.04K to 664.59K. This put 1.82% of the company's publicly available shares short.

Short interest in Oramed Pharmaceuticals Corp (XNAS:ORMP) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.

Based on the recent average volume of 206.32K shares traded per day, it would take 3.22 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.